Form 4: Labcorp Executive Exercises RSUs, Sells Shares

Megan D. Bailey, EVP and President of Central Labs & International at Labcorp, exercised Restricted Stock Units and sold shares to cover tax obligations.

Summary

• Megan D. Bailey, Executive Vice President and President of Central Labs & International at Labcorp Holdings Inc., acquired 370 shares of common stock through the exercise of Restricted Stock Units (RSUs) on November 1, 2025.
• Following this acquisition, 179 shares of common stock were disposed of on November 3, 2025, at a price of $257.84 per share to satisfy tax withholding obligations.
• After these transactions, Ms. Bailey directly owns 3,594 shares of Labcorp common stock.
• Ms. Bailey also holds 2,599 Restricted Stock Units, which represent the contingent right to receive one share of common stock per unit.
• The Restricted Stock Units are scheduled to vest in three equal annual installments beginning on November 1, 2025.

Sentiment

Score: 5

Explanation: This is a routine insider transaction involving the exercise of Restricted Stock Units and a subsequent sale of shares to cover tax obligations, which is neither strongly positive nor negative for the company's fundamental outlook.

Positives

• Executive Megan D. Bailey exercised 370 Restricted Stock Units, converting them into common stock, indicating the vesting of long-term incentives and continued alignment with shareholder interests.

Negatives

• 179 shares of common stock were disposed of to cover tax withholding obligations, resulting in a reduction of the executive's direct share ownership.

Future Outlook

Restricted Stock Units held by Megan D. Bailey are scheduled to vest in three equal annual installments beginning on November 1, 2025.

Stakeholder Impact

• Shareholders: This is a routine executive compensation event, with minimal direct impact on the company's overall share structure or valuation. The sale of shares for tax purposes is a common practice and does not necessarily reflect a change in the executive's confidence in the company.

Next Steps

• The remaining 2,599 Restricted Stock Units will continue to vest in subsequent equal annual installments after November 1, 2025.

Key Dates

Recommendation

This Form 4 details a routine insider transaction where an executive exercised Restricted Stock Units and subsequently sold a portion of the shares to cover tax obligations. Such transactions are common and generally do not indicate a change in the company's fundamental performance or outlook, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Labcorp, LH, insider transaction, Form 4, executive compensation, Restricted Stock Units, RSU exercise, share sale, Megan D. Bailey